Oprymea (Pramipexole)

Pramipexole, the active ingredient in Oprymea, is a dopamine agonist presented as a unknown/unknown for oral use. It treats symptoms of Parkinson's disease and is used in adults.

GNH USA supplies Oprymea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pramipexole is a dopamine‑activating medication that works within the motor‑control pathway of the central nervous system. - Parkinson's disease: Improves the control of tremor and rigidity by reducing off‑  off the … - Restless Leg Disease RLD ​    ...  .... .... ...  -     ... ...

...

{"...":"..."}